United States - English - NLM (National Library of Medicine)

atlantic biologicals corps - omega-3-acid ethyl esters (unii: d87ygh4z0q) (omega-3 fatty acids - unii:71m78end5s) - omega-3-acid ethyl esters 900 mg - lovaza (omega-3-acid ethyl esters) is indicated as an adjunct to diet to reduce triglyceride (tg) levels in adult patients with severe (≥500 mg/dl) hypertriglyceridemia (htg). ® patients should be placed on an appropriate lipid-lowering diet before receiving lovaza and should continue this diet during treatment with lovaza. usage considerations: laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting therapy with lovaza. every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities. medications known to exacerbate hypertriglyceridemia (such as beta blockers, thiazides, estrogens) should be discontinued or changed if possible prior to consideration of triglyceride-lowering drug therapy. limitations of use: the effect

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

teva takeda pharma ltd. - omega-3-acid ethyl esters - colorless to light-yellow clear spherical capsule, diameter: approx. 4 mm

Australia - English - Department of Health (Therapeutic Goods Administration)

australian natural health pharmaceuticals pty ltd - ubidecarenone, quantity: 150 mg; d-alpha-tocopherol, quantity: 33.6 mg (equivalent: d-alpha-tocopherol, qty 50.1 iu); natural fish oil, quantity: 500 mg (equivalent: eicosapentaenoic acid, qty 90 mg; equivalent: docosahexaenoic acid, qty 60 mg) - capsule, soft - excipient ingredients: yellow beeswax; hydrogenated vegetable oil; soya oil; gelatin; lecithin; glycerol; sunset yellow fcf; lime oil coldpressed; titanium dioxide; iron oxide red; purified water; lemon oil - antioxidant/reduce free radicals formed in the body ; maintain/support general health and wellbeing ; maintain/support cardiovascular system health ; maintain/support heart health

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - recombinant omega interferon of feline origin - parenteral liquid/solution/suspension - recombinant omega interferon of feline origin vaccine active 10.0 mu/ml - immunotherapy - cat | dog - adult | cat - queen | cat - tom | kitten - canine parvovirus | feline calicivirus | calicivirus (feline) | fcv | parvovirus

Australia - English - Department of Health (Therapeutic Goods Administration)

successfield pty ltd - ubidecarenone, quantity: 150 mg; d-alpha-tocopherol, quantity: 50 mg (equivalent: d-alpha-tocopherol, qty 50 iu); natural fish oil, quantity: 500 mg (equivalent: eicosapentaenoic acid, qty 90 mg; equivalent: docosahexaenoic acid, qty 60 mg) - capsule, soft - excipient ingredients: titanium dioxide; sunset yellow fcf; lemon oil; lime oil distilled; purified water; iron oxide red; lecithin; soya oil; glycerol; yellow beeswax; gelatin; hydrogenated coconut oil - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support energy production ; helps enhance/promote general health and wellbeing ; maintain/support general health and wellbeing ; helps enhance/promote joint health ; maintain/support joint health ; maintain/support cardiovascular system health ; helps maintain/support healthy heart function ; maintain/support healthy cardiovascular system function ; maintain/support heart health ; maintain/support brain function ; maintain/support brain health

Australia - English - Department of Health (Therapeutic Goods Administration)

phytologic holdings pty limited - ubidecarenone, quantity: 150 mg; natural fish oil, quantity: 150 mg (equivalent: omega-3 marine triglycerides, qty 45 mg); d-alpha-tocopherol, quantity: 33.6 mg - capsule, soft - excipient ingredients: purified water; lecithin; iron oxide red; hydrogenated coconut oil; soya oil; yellow beeswax; glycerol; gelatin - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support energy levels ; enhance/promote/physical endurance/capacity/stamina ; maintain/support physical endurance/capacity/stamina ; maintain/support general health and wellbeing ; maintain/support blood circulation/flow to the peripheral areas of the body (legs, hands and feet) ; helps in the maintenance of healthy blood lipids/blood fats ; helps maintain/support healthy cholesterol ; maintain/support blood health ; maintain/support cardiovascular system health ; maintain/support heart health ; helps enhance/promote blood vessel health ; helps enhance/improve/promote/increase physical/exercise performance ; maintain/support (state vitamin/mineral/nutrient) levels in the body

Australia - English - Department of Health (Therapeutic Goods Administration)

omegapharm - acetylcysteine -

Australia - English - Department of Health (Therapeutic Goods Administration)

omegapharm - mitomycin, quantity: 20 mg - injection, powder for - excipient ingredients: mannitol - mitomycin is indicated in the palliative treatment of carcinoma of the stomach, pancreas, colon, lung (non-small cell), breast, cervix, head and neck, liver and bladder.

Australia - English - Department of Health (Therapeutic Goods Administration)

omegapharm - mitomycin, quantity: 10 mg - injection, powder for - excipient ingredients: mannitol - mitomycin is indicated in the palliative treatment of carcinoma of the stomach, pancreas, colon, lung (non-small cell), breast, cervix, head and neck, liver and bladder.

Australia - English - Department of Health (Therapeutic Goods Administration)

omegapharm - mitomycin, quantity: 2 mg - injection, powder for - excipient ingredients: mannitol - mitomycin is indicated in the palliative treatment of carcinoma of the stomach, pancreas, colon, lung (non-small cell), breast, cervix, head and neck, liver and bladder.